- Author:Jerry J. Buccafusco
- Publisher:Birkhäuser; 2004 edition (February 20, 2004)
- Pages:203 pages
- FB2 format1135 kb
- ePUB format1470 kb
- DJVU format1328 kb
- Formats:lrf rtf lrf lit
Milestones in Drug Therapy. Cognitive Enhancing Drugs. price for USA in USD (gross).
Milestones in Drug Therapy. ISBN 978-3-0348-7867-8.
Series: Milestones in Drug Therapy MDT. File: PDF, . 0 M. Other readers will always be interested in your opinion of the books you've read. Whether you've loved the book or not, if you give your honest and detailed thoughts then people will find new books that are right for them. 0 MB. Читать онлайн.
Cognitive Enhancing Drugs book. Cognitive Enhancing Drugs (Milestones In Drug Therapy).
Cognitive Enhancing Drugs. Cognitive Enhancing Drugs Milestones in Drug Therapy. by. series Milestones in Drug Therapy.
Zagreb, Croatia Jacques Bruinvels, Bilthoven, The Netherlands Advisory Board . Zagreb, Croatia Jacques Bruinvels, Bilthoven, The Netherlands Advisory Board . Buckingham, Imperial College School of Medicine, London, UK . Herman, Universiteit Antwerpen, Antwerp, Belgium P. Skolnick, National Institute on Drug Abuse, Bethesda, MD
Buccafusco J, ed. 2004
Buccafusco J, ed. 2004. Evaluating potential disease-modifying drugs will require excellent biomarkers, said Gary Small of the University of California, Los Angeles, who focused on potential applications of neuroimaging in the early detection of cognitive decline.
The book comprehensively discusses a wide variety of animal models of cognitive impairment, including genetic, lesion, pharmacological, and aging related impairments.
This book is organized chronologically, beginning with entries on the use of Herbs and Alcohol from the dawn of mankind and ending with . As the author points out, drugs have had a major impact on the quality and length of life.
This book is organized chronologically, beginning with entries on the use of Herbs and Alcohol from the dawn of mankind and ending with a glimpse at the future with a discussion of Female Viagra and Gene therapy. Entries consist of a few paragraphs on one page, with a photo or illustration on the facing page. There is a brief bibliography for each entry located at the back of the book, and a thorough index leads browsers directly to key people and specific drugs.
Moreover, a multiplicity of novel, improved irreversibly acting small molecular HER tyrosine kinase inhibitors are in the pipeline of many drug developing companies and are being evaluated in the clinical setting.
During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer`s disease, attention is also being focused on issues relating to cognitive impairment associated with "normal" aging. This book is useful as a source of information for making informed decisions regarding the relative utility and attributes of the various neural targets that have been studied to date.